National and Kapodistrian University of Athens
Αιμοστατικοί δείκτες σε πλασματικά παράγωγα αίματος
Abstract
dc:descriptionIntroduction: Despite the fact that there are clear guidelines on industrial manufacture of plasma-derived medicinal products, there is no expiration date for plasma intended for fractionation and the effect of prolonged storage remains unknown. Furthermore, although factor VIII (FVIII) is the quality assurance indicator of plasma, global assays could more accurately reflect the hemostatic profile of plasma. Aim: The aim of this study was to investigate the effect of prolonged storage on the degradation kinetics and stability of various coagulation factors and inhibitors, as well as to analyze recovered plasma stored for a long period of time using a global method and correlate the results with the activity of FVIII. Materials and methods: Two separate studies were performed. In both, units of recovered plasma, which had been stored at –30 °C at the National Blood Donation Center for up to 11 years and came from a temporarily inactive fractionation program were examined. In the first part of the study, a total of 237 plasma units stored for one year (62 units), five years (75 units) and 10 years (100 units) were examined. The factors studied were: FII, FV, FVII, FVIII, FIX, FX, FXI, FXII, FXIII, fibrinogen, antithrombin (AT) and albumin. Comparison of values between 1 and 5, 1 and 10 and 5 and 10 years of storage was performed. In the second part of the study, a total of 60 plasma units, stored for 11 years (12 units), 7 years (18 units), 3 years (17 units) and 2 years (13 units) were examined. The analyses were performed using rotational thromboelastometry (ROTEM®, Munich, Germany) without accelerating activators (NATEM assay). The results were correlated with the activity of FVIII.Results: Albumin, AT, fibrinogen, FIX, FXI, FXII and FXIII remain rather stable even after 10 years of storage. The levels of FII, FV, FVII, FVIII and FX decreased after 5 years of storage. Despite the decrease in FVIII, most ROTEM parameters (CT, CFT, α-angle, LI30 and LI60) were within normal range regardless of storage time. Conclusions: Recovered plasma could possibly be used for industrial manufacture of medicinal products after several years of storage at the recommended temperature. If confirmed in further studies, global methods, such as thromboelastometry, could more accurately assess the hemostatic potential of recovered plasma.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kontoteza, Ifigenia-Vasiliki
- Κοντοτέζα, Ιφιγένεια-Βασιλική
Subjects
dc:subject × 16- Πλάσμα ανάκτησης
- Παράγοντες πήξης
- Περιστροφική θρομβοελαστομετρία
- Recovered plasma
- Clotting factors
- Rotational thromboelastometry (ROTEM)
- Επιστήμες Υγείας
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες υγείας, άλλοι τομείς
- Βασική Ιατρική
- Βασική ιατρική, γενικά
- Health Sciences
- Medical and Health Sciences
- Health sciences, miscellaneous
- Basic Medicine
- Basic medicine, general
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/58895